View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Stefan Zeuzem, MD, discusses exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.
Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany
Dr Graham Foster on optimizing management of HBV in older adults, from Clinical Care Options (CCO)
Graham R. Foster, FRCP, PhD
Released: January 17, 2023
Expert analysis by Dr Nancy Reau on new viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)
Nancy Reau, MD
Released: December 8, 2022
Clinical Care Options (CCO) expert analysis by Dr Stefan Zeuzem on new viral hepatitis data from AASLD 2022
Stefan Zeuzem, MD
Released: December 8, 2022
Dr Nancy Reau: practice-changing viral hepatitis data from AASLD 2022, from Clinical Care Options (CCO)
Nancy Reau, MD
Released: December 6, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.